Evidence map›Paper›PMID 33393511›Full record

ReviewThe Journal of clinical investigation2021

Carbohydrate restriction for diabetes: rediscovering centuries-old wisdom.

Belinda S Lennerz, Andrew P Koutnik, Svetlana Azova, Joseph I Wolfsdorf, David S Ludwig

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05899166 (Effect of Dietary Carbohydrate on Diabetes Control and Beta Cell Function in Children With Newly Diagnosed Diabetes), which is not on this map. Cited by 41 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 3 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05899166 narecruitingnot on this mapstarted 2024, after this paper: background citation

Effect of Dietary Carbohydrate on Diabetes Control and Beta Cell Function in Children With Newly Diagnosed Diabetes

TypeinterventionalSponsorBoston Children's HospitalRan2024 to 2029Enrolled52ConditionsDiabetes Mellitus, Type 1ArmsKetogenic diet, food delivery and education, Standard diet, food delivery and education
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 3 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Prolonging Partial Remission in Type 1 Diabetes: The Role of Low-Carbohydrate Diet: A Literature Review.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Low-carbohydrate diet for people with type 2 diabetes mellitus.The Cochrane database of systematic reviews · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Belinda S LennerzNew Balance Foundation Obesity Prevention Center, Boston Children's Hospital, and.
Andrew P KoutnikHuman Health, Resilience & Performance, Institute for Human and Machine Cognition, and.
Svetlana AzovaNew Balance Foundation Obesity Prevention Center, Boston Children's Hospital, and.
Joseph I WolfsdorfDivision of Endocrinology, Boston Children's Hospital, Boston, Massachusetts, USA.
David S LudwigNew Balance Foundation Obesity Prevention Center, Boston Children's Hospital, and.
Boston Children's Hospital · USFlorida Institute for Human and Machine Cognition · US

Funding

Research in Development Endocrinology and MetabolismT32DK007699 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI JOEL N HIRSCHHORN · 1992 to 2026
$7.1M
Effects of dietary carbohydrate on postprandial metabolism, brain function and type 1 diabetes controlK23DK119546 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI LENNERZ, BELINDA S · 2018 to 2021
$680k
NIDDK NIH HHS K23 DK119546NIDDK NIH HHS T32 DK007699
6 · The paper itself

Abstract

Carbohydrate restriction, used since the 1700s to prolong survival in people with diabetes, fell out of favor after the discovery of insulin. Despite costly pharmacological and technological developments in the last few decades, current therapies do not achieve optimal outcomes, and most people with diabetes remain at high risk for micro- and macrovascular complications. Recently, low-carbohydrate diets have regained popularity, with preliminary evidence of benefit for body weight, postprandial hyperglycemia, hyperinsulinemia, and other cardiometabolic risk factors in type 2 diabetes and, with more limited data, in type 1 diabetes. High-quality, long-term trials are needed to assess safety concerns and determine whether this old dietary approach might help people with diabetes attain clinical targets more effectively, and at a lower cost, than conventional treatment.

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diet, Carbohydrate-RestrictedCardiometabolic Risk FactorsHumansHyperglycemiaInsulinInsulin

Identifiers

PMID33393511
PMCPMC7773350
OpenAlexW3120234758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.